sarpogrelate has been researched along with Coronary Stenosis in 1 studies
sarpogrelate: structure given in first source
Coronary Stenosis: Narrowing or constriction of a coronary artery.
Excerpt | Relevance | Reference |
---|---|---|
"8 years with 10-75% coronary artery stenosis, as assessed by coronary computed tomography angiography, were randomly assigned to sarpogrelate 300 mg/day plus aspirin 100 mg/day (SPG + ASA group) or aspirin 100 mg/day alone (ASA group) for 6 months." | 5.24 | Effect of sarpogrelate, a selective 5-HT ( Chun, EJ; Han, SJ; Hur, JH; Jang, HC; Kang, DK; Kim, HJ; Kim, KM; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lee, DH | 1 |
Chun, EJ | 1 |
Hur, JH | 1 |
Min, SH | 1 |
Lee, JE | 1 |
Oh, TJ | 1 |
Kim, KM | 1 |
Jang, HC | 1 |
Han, SJ | 1 |
Kang, DK | 1 |
Kim, HJ | 1 |
Lim, S | 1 |
1 trial available for sarpogrelate and Coronary Stenosis
Article | Year |
---|---|
Effect of sarpogrelate, a selective 5-HT
Topics: Adult; Aged; Ankle Brachial Index; Anti-Inflammatory Agents; Aspirin; Biomarkers; Computed Tomograph | 2017 |